Andrx Pharmaceuticals, Inc.

Andex Pharmaceuticals, Inc.

Timothy Weng

Chih-Ming Chen

Joseph C Chou

Mongkol Sriwongjanya

Unchalee Kositprapa

Joseph C H Chou

David Barman

A controlled release pharmaceutical formulation for the administration of an antihistamine and decongestant to a patient wherein the formulation employs a compressed matrix core for the controlled release of a decongestant and an immediate release coating for the immediate release of the antihistamine.

Once a day antihistamine and decongestant formulation

Omeprazole formulation

A controlled release dosage form for an analgesic that does not contain an expanding polymer and comprising a core containing the analgesic, preferably tramadol or it pharmaceutically acceptable deviates and a semipermeable membrane coating the core.

Controlled release oral dosage form

A pharmaceutical composition of omeprazole for oral administration is described which consists essentially of: (a) a pellet comprising an inert core component, a therapeutically effective amount of omeprazole, a surface active agent, a filler, a pharmaceutically acceptable alkaline agent and a binder; and (b) a single layer of coating on said pellet which comprises a layer of an enteric coating agent.

A pharmaceutical composition of omeprazole for oral administration is described which consists essentially of:

Growing community of inventors

Plantation, FL, United States of America

Timothy Weng